cinrebafusp alfa
pieris pharmaceuticals,servier
['prs-343']
pieris pharmaceuticals announces presentation of positive clinical data for cinrebafusp alpa (prs-343) at 2023 aacr annual meeting $pirs 
Real-Time News, Market Data and Stock Quotes for Biotech, Pharma, and Healthcare Stocks